Back to search results

Bladder Cancer Biorepository for Research

This observational study is creating a registry, which is like a 'bank' of information from people with bladder cancer. Researchers will use this information to learn more about how bladder cancer develops, comes back, and affects long-term survival. They will also study how bladder cancer tissues are related to these outcomes. You can join if you are 18 or older and have a diagnosis or suspected diagnosis of bladder cancer. The study aims to collect information from 1000 participants. Success will be measured by understanding the blood, urine, and tissue characteristics of bladder cancer patients over 24 months.

Study design
This is an observational study that aims to enroll 1000 participants. It involves creating a patient registry.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint measures characteristics of bladder cancer patients at 24 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03413982

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Recruiting
Not specifiedAges 18+Observational
University of Kansas Medical Center
~1,000 participants
Updated 2026-03-10 on ClinicalTrials.gov
What's tested:Registry

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Blood, urine and tissue characteristics of bladder cancer patients
Measured over 24 months

Conditions

Bladder Cancer

Explore related trials

Bladder Carcinoma

NCT03413982

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Kansas Medical Center

    Kansas City, Kansasno site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • John Taylor, MD · PRINCIPAL_INVESTIGATOR · University of Kansas Medical Center

Who to contact

Jane Ladesma
[email protected]
913-588-8721
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
Patients can participate in any additional research studies during the patients' participation within this protocol.

Exclusion

Patients who do not have presumed bladder cancer will not be eligible

What this trial measures

  • Blood, urine and tissue characteristics of bladder cancer patients24 months

    Samples will be collected over a 24 month period for patients to build a biorepository for future research on how they are related to tumor development, recurrence and survival.